Profound Financial Statements From 2010 to 2025

PROF Stock  USD 6.76  0.05  0.73%   
Profound Medical financial statements provide useful quarterly and yearly information to potential Profound Medical Corp investors about the company's current and past financial position, as well as its overall management performance and changes in financial position over time. Historical trend examination of various income statement and balance sheet accounts found on Profound Medical financial statements helps investors assess Profound Medical's valuation, profitability, and current liquidity needs. Key fundamental drivers impacting Profound Medical's valuation are summarized below:
Gross Profit
M
Profit Margin
(2.60)
Market Capitalization
204.6 M
Enterprise Value Revenue
14.217
Revenue
10.7 M
There are over one hundred nineteen available trending fundamental ratios for Profound Medical Corp, which can be analyzed over time and compared to other ratios. Active traders should verify all of Profound Medical Corp recent fundamental drivers against the trend between 2010 and 2025 to make sure the company can sustain itself down the road. The Profound Medical's current Market Cap is estimated to increase to about 244.7 M. The Profound Medical's current Enterprise Value is estimated to increase to about 197.4 M

Profound Medical Total Revenue

5.37 Million

Check Profound Medical financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Profound Medical's main balance sheet or income statement drivers, such as Depreciation And Amortization of 1.3 M, Interest Expense of 731 K or Selling General Administrative of 24.3 M, as well as many indicators such as Price To Sales Ratio of 33.11, Dividend Yield of 0.0 or PTB Ratio of 3.42. Profound financial statements analysis is a perfect complement when working with Profound Medical Valuation or Volatility modules.
  
Check out the analysis of Profound Medical Correlation against competitors.

Profound Medical Balance Sheet

Current ValueLast YearHistorical Average 10 Year Trend
Total Assets49.1 M70.2 M34.1 M
Slightly volatile
Short and Long Term Debt Total6.8 M5.1 M5.3 M
Slightly volatile
Total Current Liabilities5.3 M6.6 M3.7 M
Slightly volatile
Total Stockholder Equity38.9 M60.4 M27.1 M
Slightly volatile
Property Plant And Equipment Net464.6 K489 K913.6 K
Slightly volatile
Accounts Payable2.5 M1.3 M1.7 M
Slightly volatile
Cash34.9 M54.9 M24.4 M
Slightly volatile
Non Current Assets Total712.5 K750 K2.9 M
Slightly volatile
Cash And Short Term Investments35.7 M54.9 M24.9 M
Slightly volatile
Net Receivables4.1 MM3.1 M
Slightly volatile
Common Stock Total Equity255.4 M243.3 M113.3 M
Slightly volatile
Common Stock Shares Outstanding13.8 M24.8 M9.6 M
Slightly volatile
Liabilities And Stockholders Equity49.1 M70.2 M34.1 M
Slightly volatile
Non Current Liabilities Total5.1 M3.2 M4.2 M
Slightly volatile
Total Liabilities10.1 M9.8 MM
Slightly volatile
Property Plant And Equipment Gross2.1 M3.2 M1.5 M
Slightly volatile
Total Current Assets44.6 M69.1 M31 M
Slightly volatile
Short Term Debt1.8 MM1.4 M
Pretty Stable
Intangible Assets247.9 K261 K927.3 K
Pretty Stable
Common Stock151.4 M281.6 M104.5 M
Slightly volatile
Other Liabilities1.1 M878.6 K724.5 K
Slightly volatile
Net Tangible Assets38 M59 M28.8 M
Slightly volatile
Long Term Debt5.7 M2.9 M5.5 M
Very volatile
Long Term Debt Total6.4 M10.2 M6.8 M
Slightly volatile
Capital Surpluse23.6 M22.5 M11.4 M
Slightly volatile
Short and Long Term Debt1.9 M1.7 M1.4 M
Slightly volatile
Property Plant Equipment1.7 MM1.2 M
Slightly volatile
Net Invested Capital56 M65.1 M35.7 M
Slightly volatile
Net Working Capital50 M62.5 M28.3 M
Slightly volatile
Capital Stock208.1 M281.6 M140.2 M
Slightly volatile

Profound Medical Income Statement

Current ValueLast YearHistorical Average 10 Year Trend
Depreciation And Amortization1.3 M1.3 M921.9 K
Slightly volatile
Interest Expense731 K839.5 K705 K
Very volatile
Selling General Administrative24.3 M23.1 M7.4 M
Slightly volatile
Other Operating Expenses25.7 M43.7 M18.8 M
Slightly volatile
Research Development10.9 M17 M8.1 M
Slightly volatile
Total Operating Expenses23.4 M40.1 M17.2 M
Slightly volatile
Interest IncomeM1.9 M1.1 M
Very volatile
Selling And Marketing Expenses5.5 M10.9 M3.9 M
Slightly volatile
Reconciled Depreciation1.5 M936 K1.1 M
Slightly volatile

Profound Medical Cash Flow Statement

Current ValueLast YearHistorical Average 10 Year Trend
Stock Based Compensation2.5 M2.6 M1.8 M
Slightly volatile
Begin Period Cash Flow29.6 M26.2 M20.5 M
Slightly volatile
Depreciation1.1 M936 K769 K
Slightly volatile
Other Non Cash Items242.2 K255 K2.7 M
Slightly volatile
Total Cash From Financing Activities57.4 M54.7 M18.7 M
Slightly volatile
End Period Cash Flow35.1 M54.9 M25 M
Slightly volatile
Sale Purchase Of Stock15.6 M10.4 M18.1 M
Slightly volatile
Change To Netincome4.6 M7.9 M4.8 M
Slightly volatile

Financial Ratios

Current ValueLast YearHistorical Average 10 Year Trend
Price To Sales Ratio33.1117.406124.0071
Slightly volatile
PTB Ratio3.423.07663.5458
Slightly volatile
Days Sales Outstanding317241310
Slightly volatile
Book Value Per Share3.432.43933.9349
Slightly volatile
Average Payables2.5 M2.4 M1.5 M
Slightly volatile
Stock Based Compensation To Revenue0.380.24170.381
Slightly volatile
Capex To Depreciation0.340.360.8426
Pretty Stable
PB Ratio3.423.07663.5458
Slightly volatile
EV To Sales12.1112.74419.4711
Slightly volatile
Payables Turnover2.92.76610.9831
Slightly volatile
Sales General And Administrative To Revenue1.631.461.3716
Slightly volatile
Research And Ddevelopement To Revenue2.411.58852.106
Very volatile
Capex To Revenue0.07540.09920.0831
Slightly volatile
Cash Per Share3.562.21694.1448
Slightly volatile
Days Payables Outstanding1251321.3 K
Slightly volatile
Income Quality0.620.84310.6596
Slightly volatile
Intangibles To Total Assets0.00350.00370.0553
Very volatile
Current Ratio8.3910.520211.3171
Pretty Stable
Tangible Book Value Per Share3.152.42883.6988
Slightly volatile
Receivables Turnover1.321.5161.3853
Pretty Stable
Shareholders Equity Per Share3.432.43933.9349
Slightly volatile
Debt To Equity0.08050.08480.8258
Slightly volatile
Capex Per Share0.03170.03330.1204
Slightly volatile
Graham Net Net2.852.15123.5361
Slightly volatile
Average ReceivablesM3.1 M3.8 M
Slightly volatile
Revenue Per Share0.420.43120.4952
Slightly volatile
Interest Debt Per Share0.20.20674.7827
Slightly volatile
Debt To Assets0.06930.07290.7058
Slightly volatile
Price Book Value Ratio3.423.07663.5458
Slightly volatile
Days Of Payables Outstanding1251321.3 K
Slightly volatile
Ebt Per Ebit1.160.84141.2507
Slightly volatile
Company Equity Multiplier1.61.16241.3664
Pretty Stable
Long Term Debt To Capitalization0.04390.04620.3108
Slightly volatile
Total Debt To Capitalization0.07420.07810.3431
Slightly volatile
Debt Equity Ratio0.08050.08480.8258
Slightly volatile
Quick Ratio7.829.636610.788
Slightly volatile
Net Income Per E B T0.80.99990.9977
Slightly volatile
Cash Ratio6.68.36449.6651
Slightly volatile
Days Of Sales Outstanding317241310
Slightly volatile
Free Cash Flow Operating Cash Flow Ratio1.131.181.0418
Slightly volatile
Price To Book Ratio3.423.07663.5458
Slightly volatile
Fixed Asset Turnover13.6613.00844.3057
Slightly volatile
Debt Ratio0.06930.07290.7058
Slightly volatile
Price Sales Ratio33.1117.406124.0071
Slightly volatile
Asset Turnover0.0960.15210.1418
Slightly volatile
Gross Profit Margin0.390.65890.4349
Slightly volatile
Price Fair Value3.423.07663.5458
Slightly volatile

Profound Medical Valuation Data

Current ValueLast YearHistorical Average 10 Year Trend
Market Cap244.7 M185.9 M190.8 M
Slightly volatile
Enterprise Value197.4 M136.1 M169.5 M
Pretty Stable

Profound Fundamental Market Drivers

Cash And Short Term Investments54.9 M

Profound Upcoming Events

5th of March 2024
Upcoming Quarterly Report
View
8th of May 2024
Next Financial Report
View
31st of December 2023
Next Fiscal Quarter End
View
5th of March 2024
Next Fiscal Year End
View
30th of September 2023
Last Quarter Report
View
31st of December 2022
Last Financial Announcement
View

About Profound Medical Financial Statements

Profound Medical stakeholders use historical fundamental indicators, such as Profound Medical's revenue or net income, to determine how well the company is positioned to perform in the future. Although Profound Medical investors may analyze each financial statement separately, they are all interrelated. For example, changes in Profound Medical's assets and liabilities are reflected in the revenues and expenses on Profound Medical's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Profound Medical Corp. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Current Deferred Revenue419 K391.4 K
Total Revenue10.7 M5.4 M
Cost Of Revenue3.6 M2.9 M
Stock Based Compensation To Revenue 0.24  0.38 
Sales General And Administrative To Revenue 1.46  1.63 
Research And Ddevelopement To Revenue 1.59  2.41 
Capex To Revenue 0.10  0.08 
Revenue Per Share 0.43  0.42 
Ebit Per Revenue(3.10)(3.25)

Currently Active Assets on Macroaxis

When determining whether Profound Medical Corp is a strong investment it is important to analyze Profound Medical's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Profound Medical's future performance. For an informed investment choice regarding Profound Stock, refer to the following important reports:
Check out the analysis of Profound Medical Correlation against competitors.
You can also try the Portfolio Analyzer module to portfolio analysis module that provides access to portfolio diagnostics and optimization engine.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Profound Medical. If investors know Profound will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Profound Medical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(1.12)
Revenue Per Share
0.431
Quarterly Revenue Growth
1.079
Return On Assets
(0.36)
Return On Equity
(0.61)
The market value of Profound Medical Corp is measured differently than its book value, which is the value of Profound that is recorded on the company's balance sheet. Investors also form their own opinion of Profound Medical's value that differs from its market value or its book value, called intrinsic value, which is Profound Medical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Profound Medical's market value can be influenced by many factors that don't directly affect Profound Medical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Profound Medical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Profound Medical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Profound Medical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.